tiprankstipranks
Trending News
More News >
C'BON COSMETICS Co., Ltd. (JP:4926)
:4926
Japanese Market

C'BON COSMETICS Co., Ltd. (4926) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4926

C'BON COSMETICS Co., Ltd.

(4926)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
¥1,245.00
▲(4.80% Upside)
The score is driven primarily by solid financial stability from a debt-free balance sheet, offset by weak cash flow (negative operating and deeply negative free cash flow). Technicals are neutral-to-mixed, while valuation is reasonable with a moderate dividend yield and mid-range P/E.
Positive Factors
Balance Sheet Strength
A debt-free balance sheet reduces refinancing and solvency risk, providing financial stability and flexibility to navigate downturns.
Revenue Growth
Stable revenue growth indicates resilience in the company's business model, supporting long-term market presence and customer retention.
Profitability Improvement
Improved profitability reflects effective cost management and operational efficiency, enhancing the company's ability to reinvest in growth.
Negative Factors
Cash Flow Weakness
Negative cash flow indicates challenges in cash conversion, which may hinder the company's ability to fund operations and growth initiatives.
Thin Margins
Thin margins suggest limited pricing power and cost pressures, which could impact profitability and competitive positioning over time.
Volatile Earnings
Earnings volatility indicates potential instability in revenue streams and cost structures, posing risks to consistent financial performance.

C'BON COSMETICS Co., Ltd. (4926) vs. iShares MSCI Japan ETF (EWJ)

C'BON COSMETICS Co., Ltd. Business Overview & Revenue Model

Company DescriptionC'BON COSMETICS Co.,Ltd. manufactures and sells cosmetics, quasi-drugs, and beauty appliance products. It offers various products, such as cleansing, lotion, cream, face wash, serum, and makeup base products. The company was founded in 1966 and is headquartered in Kawasaki, Japan.
How the Company Makes MoneyC'BON COSMETICS Co., Ltd. generates revenue through the direct sale of its cosmetics products, which include skincare creams, lotions, and other personal care items. The company primarily sells its products through a network of retail stores, online platforms, and beauty salons. Revenue is largely driven by consumer demand for high-quality skincare solutions and the company's ability to maintain strong relationships with retail partners. Additionally, C'BON COSMETICS may engage in strategic partnerships with other brands or entities to expand its market reach and enhance its product offerings. The company's earnings are significantly influenced by its brand reputation, product innovation, and effective marketing strategies.

C'BON COSMETICS Co., Ltd. Financial Statement Overview

Summary
C'BON COSMETICS Co., Ltd. is encountering financial difficulties, with declining revenues and persistent losses. Despite a strong gross profit margin and no debt, the company faces significant challenges with negative cash flow and low profitability, necessitating strategic improvements.
Income Statement
56
Neutral
C'BON COSMETICS Co., Ltd. has experienced declining revenue from 2020 to TTM 2024, with a notable drop in net income, resulting in negative net profit margins. The gross profit margin has remained strong, indicating efficient production, but EBIT and EBITDA margins are weak, reflecting operating challenges.
Balance Sheet
86
Very Positive
The company maintains a solid equity base with no current debt, resulting in a favorable debt-to-equity ratio. However, there has been a downward trend in stockholders' equity over recent periods, and the return on equity is negative due to consistent net losses.
Cash Flow
34
Negative
The company's cash flow position is concerning, with negative free cash flow and inconsistent operating cash flow. The lack of free cash flow growth and an inability to generate cash from operations suggest financial instability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue9.02B8.84B8.50B8.53B9.15B9.10B
Gross Profit6.91B6.74B6.40B6.34B7.10B6.92B
EBITDA404.41M292.59M168.64M-92.22M329.61M-345.64M
Net Income253.04M136.27M-26.35M-421.77M44.87M-621.87M
Balance Sheet
Total Assets8.67B8.52B8.81B8.84B9.56B9.56B
Cash, Cash Equivalents and Short-Term Investments2.54B2.65B3.63B3.98B2.80B2.32B
Total Debt0.000.004.24M13.27M22.30M25.20M
Total Liabilities3.00B2.82B3.15B3.13B3.36B1.97B
Stockholders Equity5.67B5.70B5.66B5.71B6.20B7.60B
Cash Flow
Free Cash Flow0.00-926.52M-313.38M-700.71M321.35M-829.87M
Operating Cash Flow0.00-43.16M278.19M-81.47M433.37M-694.00M
Investing Cash Flow0.00-849.16M-581.94M1.35B44.91M161.38M
Financing Cash Flow0.00-90.22M-31.20M-91.29M-6.73M-6.80M

C'BON COSMETICS Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1188.00
Price Trends
50DMA
1204.82
Positive
100DMA
1201.22
Positive
200DMA
1162.05
Positive
Market Momentum
MACD
13.91
Negative
RSI
82.77
Negative
STOCH
67.35
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4926, the sentiment is Positive. The current price of 1188 is below the 20-day moving average (MA) of 1217.85, below the 50-day MA of 1204.82, and above the 200-day MA of 1162.05, indicating a bullish trend. The MACD of 13.91 indicates Negative momentum. The RSI at 82.77 is Negative, neither overbought nor oversold. The STOCH value of 67.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4926.

C'BON COSMETICS Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥159.34B19.845.00%1.41%0.75%
68
Neutral
¥2.13B6.2112.96%
68
Neutral
¥2.55B10.781.72%-6.06%-97.12%
63
Neutral
¥6.58B8.432.38%-0.79%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
¥6.62B48.431.59%-9.99%-35.06%
58
Neutral
¥5.33B17.041.68%8.46%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4926
C'BON COSMETICS Co., Ltd.
1,258.00
213.55
20.45%
JP:4918
Ivy Cosmetics Corporation
386.00
140.00
56.91%
JP:4920
Nippon Shikizai, Inc.
1,216.00
52.36
4.50%
JP:4925
HABA Laboratories, Inc.
1,739.00
123.60
7.65%
JP:4928
Noevir Holdings Co., Ltd.
4,685.00
331.70
7.62%
JP:4929
ADJUVANT HOLDINGS CO., LTD.
810.00
6.77
0.84%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025